These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 3280522
1. Gd-DTPA: an i.v. contrast agent for clinical MRI. Runge VM. Int J Rad Appl Instrum B; 1988; 15(1):37-44. PubMed ID: 3280522 [No Abstract] [Full Text] [Related]
2. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT]. Tsuji T, Kishikawa T, Ikezaki K, Fujii K, Matsumoto S, Koga T. Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928 [No Abstract] [Full Text] [Related]
5. Total cerebrospinal fluid enhancement following intravenous Gd-DTPA administration in a case of meningiomatosis. Berger B, Ortiz O, Gold A, Hilal SK. AJNR Am J Neuroradiol; 1992 Dec; 13(1):15-8. PubMed ID: 1595433 [No Abstract] [Full Text] [Related]
8. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients. Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ. Comput Med Imaging Graph; 1994 Dec; 18(5):391-9. PubMed ID: 7954317 [Abstract] [Full Text] [Related]
9. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J, Inui K, Hori R, Kawamura Y, Endo K. Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [Abstract] [Full Text] [Related]
10. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA. Valk J, de Slegte RG, Crezee FC, Hazenberg GJ, Thjaha SI, Nauta JJ. Acta Radiol; 1987 Sep; 28(6):659-65. PubMed ID: 2962597 [Abstract] [Full Text] [Related]